Mariam Gilmore, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 26520 Cactus Ave, Moreno Valley, CA 92555 Phone: 951-486-4000 |
Dallas M Dick, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 26520 Cactus Ave, Moreno Valley, CA 92555 Phone: 951-486-4000 |
Roya Darioosh, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 26520 Cactus Ave, Moreno Valley, CA 92555 Phone: 951-486-4000 |
Dr. Earl Perez Ilano, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 26520 Cactus Ave, Dept Of Medicine, Moreno Valley, CA 92555 Phone: 951-486-4000 |
Dr. Ali Motabar, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 26520 Cactus Ave, Moreno Valley, CA 92555 Phone: 951-656-1500 Fax: 951-656-1510 |
Dafne Tatiana Moretta, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 26520 Cactus Ave, Moreno Valley, CA 92555 Phone: 951-486-4000 |
Dr. Ilho Kang, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 26520 Cactus Ave, Moreno Valley, CA 92555 Phone: 951-486-4000 |
Simon Christopher Lao Lim, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 26520 Cactus Ave, Moreno Valley, CA 92555 Phone: 951-486-4000 |
Heidi Scalzitti, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 26520 Cactus Ave, Moreno Valley, CA 92555 Phone: 951-486-5700 Fax: 951-486-5705 |
Huy Duong Au, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 26520 Cactus Ave, Moreno Valley, CA 92555 Phone: 951-486-5700 Fax: 951-486-5705 |
Brandon Lee Nathaniel, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 26520 Cactus Ave, Moreno Valley, CA 92555 Phone: 951-486-5700 Fax: 951-486-5705 |
Jay Hwang, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 26520 Cactus Ave, Moreno Valley, CA 92555 Phone: 951-486-4000 |
News Archive
InSite Vision Incorporated and Senju Pharmaceutical Co., Ltd. today announced that they have entered into a collaboration and license agreement to develop and market InSite's azithromycin ophthalmic solution using DuraSiteĀ® including AzaSiteĀ® 1% and AzaSite XtraTM 2% ocular antibiotics in Japan. Senju has agreed to pay InSite an upfront license fee, additional development milestones fees, and a percentage royalty on net sales.
Elevated levels of p21, a protein best known as a cancer fighter, may be involved in the ability of a few individuals to control HIV infection with their immune system alone.
Almost a quarter of a million individuals addicted to heroin are incarcerated in the United States each year. However, many prison systems across the country still do not offer medical treatment for heroin and opiate addiction, despite the demonstrated social, medical and economic benefits of opiate replacement therapy (ORT).
Progressive degeneration of photoreceptors-the rods and cones of the eyes-causes blinding diseases such as retinitis pigmentosa and age-related macular degeneration. While there are currently no available treatments to reverse this degeneration, a newly developed compound allows other cells in the eye to act like photoreceptors. As described in a study appearing in the February 19 issue of the Cell Press journal Neuron, the compound may be a potential drug candidate for treating patients suffering from degenerative retinal disorders.
› Verified 6 days ago